Search

VeonGen has reported encouraging early results from a clinical trial of VG801, an investigational gene therapy for Startgardt disease, a genetic retinal condition that currently has no approved treatments. 

• News
• Stargardt disease

Opus Genetics has launched an early-stage clinical trial of OPGx-MERTK, an investigational gene therapy for MERTK-related Retinitis Pigmentosa (RP), a condition that causes progressive vision loss due to photoreceptor degeneration.

• News
• Retinitis pigmentosa

Find out about our upcoming events. Whether you're looking for a webinar, a local peer support group or you're hoping to run a marathon, we've got something for you.

Are you affected by inherited sight loss? We are here to help.

Our vision is a world where everyone with inherited sight loss is able to live a fulfilling life.

If you, or a close relative, are living with a genetic sight loss condition, there may be a chance that your children will inherit it.

Dr Nikolas Pontikos is a Senior Research Fellow at UCL Institute of Ophthalmology, and has been working on inherited retinal conditions for several years.

• Case study - research
• Written

Join #TeamRetinaUK for an unforgettable Kiltwalk adventure in Glasgow, Aberdeen, Dundee or Edinburgh, throughout 2026.

• Walks & Treks
• Scotland